Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Clarissa Mathias
Os estudos de 2025 com potencial para mudar a prática no câncer de pulmão
Durante entrevista no congresso de 2025 da Sociedade Brasileira de Oncologia Clínica (SBOC), o Dr. Igor Morbeck, conversou com a Dra. Clarissa Mathias sobre os resultados mais relevantes apresentados ao longo do ano em grandes congressos internacionais. O Dr. Igor inicia com os dados de sobrevida global do CheckMate 816, seguidos das taxas de resposta patológica alcançadas com o NeoADAURA, ambos apresentados no congresso da American Society for Clinical Oncology (ASCO).
Três resultados relevantes apresentados no WCLC 2023
Neste vídeo, gravado no 11º Congresso Internacional Oncoclínicas/Dana-Farber Institute, a Dra. Clarissa Mathias e o Dr. Igor Morbeck compartilham os principais achados apresentados no World Conference on Lung Cancer 2023, recém-realizado em Singapura.
How can lung cancer prevention be improved?
The key to overcoming barriers to effective prevention and treatment in resource-restricted settings involves cooperation between multiple organisations, including medical societies, patient groups, pharmaceutical companies and regulatory agencies According to global cancer statistics from 2020, lung cancer is the leading cause of cancer death, accounting for an estimated 18% of all deaths from cancer worldwide (CA Cancer J Clin. 2021;71:209–249).
Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice | Future Oncology
According to an estimate from 2018, approximately two million new cases of lung cancer were reported worldwide (1.3 million male and 722,000 female cases). This report also indicated lung cancer had the highest rate of cancer-related mortality [1]. In Brazil, lung cancer was responsible for the highest number of cancer-related deaths in 2018. Additionally, this cancer remains the third most frequent and accounts for an annual incidence of approximately 30,000 cases [2].
Cardio-Oncology in Brazil
JACC: CardioOncology Leadership Page Ludhmila Abrahão Hajjar and Clarissa Mathias Author + information Ludhmila Abrahão Hajjar, MD, PhD, Director of Science, Technology and Innovation, Brazilian Society of Cardiology∗ (ludhmila{at}usp.br), @ludhmilahajjar and Clarissa Mathias, MD, PhD, President, Brazilian Society of Oncology@clarissamathias ↵∗Address for correspondence: Dr. Ludhmila Abrahão Hajjar, Heart Institute, University of São Paulo, Av Dr Eneas C Aguiar no.
Cardio-Oncology in Brazil: The Dimensions of a New Era in the Care of Patients
Introduction Occupying nearly one-half of South America’s landmass, Brazil is the largest country of the continent. The country has a diverse range of tropical and subtropical regions, with wetlands, grassy plains (known as savannahs), and low mountainous landscapes. That diversity also extends to the presence of many regional and social inequalities, including severe income inequality.
Lung Cancer in Brazil
Lung cancer is one of the most common incident cancers and a leading cause of cancer mortality in Brazil. Here, we aim to describe some aspects related to its prevention, diagnosis, and treatment in our country. Lung Cancer Epidemiology In Brazil, lung cancer is the second most common cancer in men and the fourth most common cancer in women, with 18,740 and 12,530 new cases, respectively, estimated for 2018 (Fig. 1Fig. 1).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Clarissa
Contact Clarissa, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack